Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong
Author:
Affiliation:
1. Institute of Digestive Disease; Hong Kong
2. Department of Medicine and Therapeutics; Hong Kong
3. State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong Kong
Funder
Food and Health Bureau
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13638/fullpdf
Reference44 articles.
1. Viral hepatitis C;Poynard;Lancet,2003
2. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013
3. Viral hepatitis C in Hong Kong;Leung;Intervirology,2006
4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fired;N. Engl. J. Med.,2002
5. Pegylated interferon-alpha-2a plus ribavirin for treatment-naïve Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial;Liu;Clin. Infect. Dis.,2008
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling study;Journal of Virus Eradication;2021-06
2. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trial;Liver International;2020-10-13
3. Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong;Digestive Diseases and Sciences;2020-05-08
4. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct‐acting antiviral therapy;Journal of Gastroenterology and Hepatology;2019-02-18
5. Economic evaluation of direct‐acting antivirals for the treatment of genotype 3 hepatitis C infection in Singapore;JGH Open;2019-02-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3